This study is accepting new patients by invitation only

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

a study on Hematologic Malignancy Hematologic Neoplasms

Summary

Location
at UC Davis UCLA UCSD UCSF
Dates
study started
study ends around
Principal Investigator
by John M. Timmerman, MD (ucla)
Headshot of John M. Timmerman
John M. Timmerman

Description

Summary

The goal of this clinical study is to learn more about the long-term safety, effectiveness and prolonged action of Kite study drugs, axicabtagene ciloleucel, brexucabtagene autoleucel, KITE-363, KITE-753, KITE-197, and anitocabtagene autoleucel in participants of Kite-sponsored interventional studies.

Keywords

Solid and Hematological Malignancies, Hematologic Neoplasms, Axicabtagene ciloleucel, Brexucabtagene autoleucel, Anitocabtagene autleucel, KITE-753, KITE-197, KITE-363, Axicabtagene Ciloleucel (KTE-C19), Brexucabtagene Autoleucel (KTE-X19)

Eligibility

You can join if…

  • The individual must have received an infusion of gene-modified cells in a completed Kite-sponsored parent study, has not withdrawn full consent, and has discontinued or completed the post-treatment follow-up period in the parent study, as applicable
  • The individual must understand and voluntarily sign an Informed Consent Form (ICF) or an Informed Assent Form prior to any study-related assessments or procedures being conducted
  • In the investigator's judgment, the individual is willing and able to complete the protocol-required follow-up schedule and comply with the study requirements for participation

You CAN'T join if...

none

Locations

  • UC San Diego Moores Cancer Center
    La Jolla California 92093 United States
  • University of California Los Angeles
    Los Angeles California 90095 United States
  • University of California Davis Comprehensive Cancer Center
    Sacramento California 95817 United States
  • University of California, San Francisco Medical Center
    San Francisco California 94143 United States
  • Children's Hospital Los Angeles
    Los Angeles California 90027 United States
  • Children's Hospital of Orange County
    Orange California 92868 United States
  • City of Hope
    Duarte California 91010 United States
  • Stanford University
    Palo Alto California 94305 United States

Lead Scientist at University of California Health

Details

Status
accepting new patients by invitation only
Start Date
Completion Date
(estimated)
Sponsor
Kite, A Gilead Company
Links
Gilead Clinical Trials Website
ID
NCT05041309
Study Type
Observational
Participants
Expecting 1000 study participants
Last Updated